Dr. Rebecca Iris Chen, MD

Dr. Chen practices at University of Texas Southwestern Medical Center at Dallas in Frisco, Texas.

Dr. Chen's NPI, 1144754623, was assigned on April 12, 2017. Dr. Chen graduated from Cleveland Medical College, Homeopathic in 2017. Dr. Chen holds California license A179153.

Dr. Chen's primary practice is University of Texas Southwestern Medical Center at Dallas, at 12500 Dallas Pkwy, Frisco, TX 75033 in Denton County. The practice phone is (214) 645-0624.

Dr. Chen's primary practice is University of Texas Southwestern Medical Center at Dallas in Frisco, Texas. Dr. Chen is also affiliated with Texas Health Hospital Frisco. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Chen to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chen practices, 4 sites in all. Vendor and product names are available with a free account.

Glaucoma specialist is Dr. Chen's primary specialty in the NPI Registry, under taxonomy code 207WX0009X. Dr. Chen is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Chen's licenses on file in 4 states: California, Texas, Florida and Ohio.

Dmand AI lists cataract, cataract surgery with lens implant, eyelid inflammation, glaucoma, glaucoma surgery, secondary membranaous cataract surgery and vision problems among the conditions Dr. Chen treats.

CMS data shows 3,583 Medicare services from Dr. Chen across 18 procedure codes in 2024, for 697 Medicare patients. Medicare paid $225,008 for them.

CMS counts 697 Medicare patients who saw Dr. Chen in 2024. The largest group is 75 to 84, with 282 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chen's median patient age at 68, with 51% women.

In 2024, Dr. Chen wrote 3,089 Medicare Part D claims for 535 patients. 61% of them were for generic drugs. CMS names the drug for 2,977 of them, across 20 drugs with 11 or more claims each, at $210,246 in total drug cost. In 2023, CMS named 1,458 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Chen for performance year 2024, reported as part of a group. Dr. Chen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 80 procedures of cataract surgery by Dr. Chen, more than 71% of the clinicians it reports for that procedure.

Dmand AI links 23 papers to Dr. Chen, published from 2015 to 2024. 2016 was the busiest year, with 5. The most frequent topics are Intraocular Pressure, Glaucoma, Open-Angle and Gonioscopy. Dr. Chen has published most often in Invest Ophthalmol Vis Sci. Dr. Chen's most frequent co-authors are Shan C. Lin, MD, Roland Y. Lee, MD and Robert N. Weinreb, MD.

CMS Open Payments shows 25 general payments to Dr. Chen from 10 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 94% of the total. Glaukos Corporation paid the most, $461.

Dmand AI lists 6 awards for Dr. Chen, most recently Heed Fellowship Award in 2021.

Dr. Chen graduated from Cleveland Medical College, Homeopathic in 2017. Dr. Chen is a member of AAO, American Glaucoma Society and Society of Heed Fellows.

Dr. Chen is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.